Biochem Biophys Res Commun 298:779784 Mulherin AJ, Oh AH, Kim H, Grieco A, Lauffer LM, Brubaker PL (2011) Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell
2.1.1.6 Follow-Up - Following the discontinuation of medication, maintain oversight of weight management outcomes, prompt the development of maintenance strategies, and contribute data to inform long-term outcomes
Wound and Bone Healing: Beyond soft tissue, this peptide aids in bone regeneration and wound healing, ensuring comprehensive recovery from various types of injuries
You might: Prefer not to take injections Want a daily routine that fits more naturally into your morning Find it easier to travel or store tablets compared to refrigerated injection pens or vials Need to change medications due to insurance coverage or availability Experience injection site issues with injectable GLP-1s Switching to an oral GLP-1 may offer more convenience, but its not the right option for everyone
1 October 2023
PMCID: PMC3180229.